Androgen Modulation of Neurodegeneration in Dopamine Neurons
Androgen Modulation of Neurodegeneration in Dopamine Neurons
批准号:
7408186
负责人:
REBECCA L CUNNINGHAM
金额:
$4.48万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-01 至 2011-02-28
关键词:
AcuteAgeAndrogen ReceptorAndrogensApoptosisApoptoticAstrocytesBehaviorBehavioralBradykinesiaCellsCessation of lifeChronicConditionCorpus striatum structureDopaminergic CellEstrogensFoundationsFunctional disorderGenderGoalsHigh PrevalenceHormonesHydrogen PeroxideIn VitroIncidenceKnowledgeLengthLesionMediatingMethodsMolecularMotorMuscle RigidityNerve DegenerationNeurodegenerative DisordersNeuronsOxidative StressOxidopamineParkinson DiseasePeripheralPlayPopulationPurposeRattusResearchRoleSex CharacteristicsSignal PathwayStanoloneSubstantia nigra structureTechniquesTestosteroneTimeTyrosine 3-MonooxygenaseWeekageddesigndopaminergic neuronhuman malehydroxyflutamidein vivomaleneuroprotectionneurotoxicity
中文摘要
描述(由申请人提供):问题:帕金森病(PD)在男性人群中的患病率较高。PD的特征在于运动功能障碍、僵硬和运动迟缓。目前的研究表明,性别在这种情况下发挥作用,因为男性有更大的PD发病率。据信,PD的潜在机制涉及导致细胞凋亡的氧化应激。在许多外周细胞和一些神经细胞中,雄激素已被证明可以增加细胞凋亡。目得:这些研究的目的是通过使用体外和体内方法来确定雄激素对氧化应激后多巴胺能细胞的影响。该建议的中心假设是,雄激素增加多巴胺能神经元对氧化应激诱导的神经毒性的细胞脆弱性。研究问题:该建议的第一个具体目的是确定氧化应激(过氧化氢)后多巴胺能N27细胞中雄激素激活的凋亡信号通路。第二个具体目的是评估雄激素对氧化应激后多巴胺能N27神经元雌激素介导的神经保护作用的影响。这些目标将通过体外分子研究来实现,有和没有星形胶质细胞和雄激素受体拮抗剂,羟基氟替卡松的存在。最后,第三个具体目标将表征雄激素对暴露于6-OHDA的老年雄性大鼠的酪氨酸羟化酶表达、神经元死亡和运动行为的体内影响,6-OHDA诱导黑质和纹状体的氧化应激和细胞凋亡。体内激素治疗组将包括性腺切除的老年男性、性腺完整的老年男性和性腺切除的老年男性加6-OHDA损伤前长期(3个月)或急性(1周)治疗时间长度的替代雄激素(睾酮或双氢睾酮)。免疫细胞化学和行为学技术将用于实现这一目标。结果:这项研究将提供关于雄激素如何调节多巴胺能细胞对氧化应激的脆弱性的基础知识。最终,这些知识可以用来提供一个基础,了解神经退行性疾病的性别差异的机制。
英文摘要
DESCRIPTION (provided by applicant): PROBLEM: Parkinson's disease (PD) has a higher prevalence in the human male population. PD is characterized by motor dysfunction, rigidity, and bradykinesia. Current research suggests that gender plays a role in this condition, since males have a greater incidence of PD. It is believed that the underlying mechanism of PD involves oxidative stress leading to cellular apoptosis. In many peripheral cells and some neuronal cells, androgens have been shown to increase apoptosis. PURPOSE: The goal of these studies is to determine androgen's effects on dopaminergic cells following oxidative stress by using both in vitro and in vivo methods. The central hypothesis of this proposal is that androgens increase cellular vulnerability to oxidative stress-induced neurotoxicity in dopaminergic neurons. RESEARCH QUESTIONS: The first specific aim of this proposal is to determine the apoptotic signaling pathways activated by androgens in dopaminergic N27 cells following oxidative stress (hydrogen peroxide). The second specific aim is designed to evaluate the effects of androgens on estrogen-mediated neuroprotection in dopaminergic N27 neurons following oxidative stress. These aims will be accomplished through in vitro molecular studies with and without the presence of astroglia cells and the androgen receptor antagonist, hydroxyflutamide. Lastly, the third specific aim will characterize the in vivo effects of androgens on tyrosine hydroxylase expression, neuronal death, and motor behavior in aged male rats exposed to 6-OHDA, which induces oxidative stress and apoptosis in the substantia nigra and striatum. In vivo hormone treatment groups will consist of gonadectomized aged males, gonadally intact aged males, and gonadectomized aged males plus replacement androgen (testosterone or dihydrotestosterone) for either a chronic (3 months) or acute (1 week) treatment time length prior to 6-OHDA lesion. Immunocytochemical and behavioral techniques will be used to accomplish this aim. OUTCOMES: This study will provide basic knowledge on how androgens modulate dopaminergic cellular vulnerability to oxidative stress. Ultimately, this knowledge can be used to provide a foundation to understanding the mechanisms underlying sex differences in neurodegenerative disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interactions between testosterone and oxidative stress in dopamine neurons
-
批准号:9277584
-
项目类别:
-
资助金额:$31.94万
-
财政年份:2015
-
负责人:REBECCA L CUNNINGHAM
-
依托单位:
Interactions between testosterone and oxidative stress in dopamine neurons
-
批准号:8984525
-
项目类别:
-
资助金额:$31.94万
-
财政年份:2015
-
负责人:REBECCA L CUNNINGHAM
-
依托单位:
Pilot study on the risks of testosterone replacement to the brain
-
批准号:8970389
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2015
-
负责人:REBECCA L CUNNINGHAM
-
依托单位:
Androgen Modulation of Neurodegeneration in Dopamine Neurons
-
批准号:7558485
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2008
-
负责人:REBECCA L CUNNINGHAM
-
依托单位:
Androgen Modulation of Neurodegeneration in Dopamine Neurons
-
批准号:7986604
-
项目类别:
-
资助金额:$2.62万
-
财政年份:2008
-
负责人:REBECCA L CUNNINGHAM
-
依托单位:
Androgen Modulation of Neurodegeneration in Dopamine Neurons
-
批准号:7777261
-
项目类别:
-
资助金额:$5.05万
-
财政年份:2008
-
负责人:REBECCA L CUNNINGHAM
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: